MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharmaceutical Online News' source. Thu, 09 Feb 2012 01:31:35 +0100 http://www.medworm.com/index.php?rid=5669437&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FEriez-High-Deflection-HD-Series-Feeders-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Eriez® High Deflection (HD) Series Feeders are designed to handle products that normally can't be fed successfully on an electromagnetic feeder. Their totally enclosed patented magnetic drive enables feeding of practically any bulk material from micron size to bulky chunks. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669437 Wed, 08 Feb 2012 19:20:00 +0100 5669437 http://www.medworm.com/index.php?rid=5669438&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSafe-Evaporation-Of-Diethyl-Ether-Assists-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The Inert Gas Purge (IGP) system, available for use with most Genevac evaporators, enables safe operation even when working with highly explosive solvents, those with a low flash point, very low auto-ignition temperature and a wide explosive vapour saturation range. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669438 Wed, 08 Feb 2012 08:26:00 +0100 5669438 http://www.medworm.com/index.php?rid=5669439&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FTSI-Announces-New-Remote-Particle-Counters-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da TSI Incorporated is pleased to announce a new range of Remote Particle Counters with 4-20 mA Analog Outputs. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669439 Wed, 08 Feb 2012 04:49:00 +0100 5669439 http://www.medworm.com/index.php?rid=5669440&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMerck-Announces-Top-Line-Results-Of-TRA-2P-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Merck, known outside the United States and Canada as MSD, recently announced the top-line results of the TRA-2P (Thrombin Receptor Antagonist in Secondary Prevention of atherothrombotic ischemic events) study of vorapaxar. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669440 Tue, 07 Feb 2012 13:30:00 +0100 5669440 http://www.medworm.com/index.php?rid=5669441&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FChina-Emerging-As-An-Innovation-Hub-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da A clutch of promising Chinese companies in the formulation and delivery (F/D) market underlines the emergence of the Asian giant as a center for biopharma innovation and entrepreneurship, even as Western pharmaceutical companies continue to enjoy technological and business advantages, according to a Lux Research report titled, "The Expanding Formulation and Delivery Market in China." (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669441 Tue, 07 Feb 2012 12:30:00 +0100 5669441 http://www.medworm.com/index.php?rid=5669442&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMarken-Enhances-Presence-In-China-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Marken announced recently that it has recently received approval for its application for an expanded business license to allow the storage and distribution of clinical trial supplies and drug product in China. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669442 Tue, 07 Feb 2012 08:19:00 +0100 5669442 http://www.medworm.com/index.php?rid=5669443&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBrooks-Life-Science-Systems-And-The-Scripps-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Brooks Life Science Systems, a division of Brooks Automation, Inc., a leading worldwide provider of automation solutions for compound and biological sample storage and management, recently announced the initiation of a technology development and commercialization partnership with The Scripps Research Institute (Scripps Research). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669443 Tue, 07 Feb 2012 08:00:00 +0100 5669443 http://www.medworm.com/index.php?rid=5669444&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSiemens-Forms-New-Companion-Diagnostics-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen - marking a major step for Siemens (NYSE: SI) into this important and fast-growing segment of the in vitro diagnostics (IVD) market. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669444 Tue, 07 Feb 2012 06:13:00 +0100 5669444 http://www.medworm.com/index.php?rid=5669445&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSix-Sigma-Deployment-For-Complete-Package-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Oliver Stauffer of PTI Inspection Systems will give a presentation on "Six Sigma Deployment for Complete Package Quality Control" during the HealthPack Conference for Medical Device Packaging in Albuquerque, New Mexico, March 6-8, 2012 at the Hyatt Regency. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669445 Tue, 07 Feb 2012 04:57:00 +0100 5669445 http://www.medworm.com/index.php?rid=5669446&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FDrug-Delivery-Hits-It-Big-In-Vegas-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Pharma and biotech experts from around the globe gathered in Las Vegas from January 25 to 27 for Drug Delivery Partnerships 2012 (DDP). Vegas seemed an appropriate location, because drug development is a high stakes game filled with risk and reward. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669446 Mon, 06 Feb 2012 21:14:00 +0100 5669446 http://www.medworm.com/index.php?rid=5669447&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FValeant-Pharmaceuticals-Completes-Divestiture-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc. (Nasdaq: MYL). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669447 Mon, 06 Feb 2012 07:31:00 +0100 5669447 http://www.medworm.com/index.php?rid=5669448&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSmarter-Particle-Sizing-On-Malvern-Booth-At-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Materials characterization company Malvern Instruments focuses on 'smarter particle sizing' as the Mastersizer 3000 laser diffraction particle size analyzer makes its Pittcon debut in 2012 (Booth #3641 Pittcon 2012, 11-15 Mar 2012, Orlando, FL). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669448 Mon, 06 Feb 2012 07:02:00 +0100 5669448 http://www.medworm.com/index.php?rid=5669449&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FEriez-5-Star-Service-Provides-Regular-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Eriez' 5-Star Service helps eliminate or reduce equipment downtime by ensuring that customers' magnetic, vibratory and inspection processing equipment is quickly back in operation and functioning at peak performance. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669449 Sun, 05 Feb 2012 08:24:00 +0100 5669449 http://www.medworm.com/index.php?rid=5669450&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FWatson-Provides-Update-On-Generic-Lidoderm-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm® patent challenge, Watson Pharmaceuticals, Inc. (NYSE: WPI) today issued the following statement: (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5669450 Fri, 03 Feb 2012 07:44:00 +0100 5669450 http://www.medworm.com/index.php?rid=5661360&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMylan-Receives-Tentative-FDA-Approval-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg (base), 20 mg (base), 40 mg (base) and 80 mg (base). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661360 Thu, 02 Feb 2012 11:10:00 +0100 5661360 http://www.medworm.com/index.php?rid=5661361&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBayer-Initiates-Expanded-Access-Program-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bayer HealthCare, LLC today announced that the U.S. Food and Drug Administration agreed that Bayer can proceed with its expanded access program to provide the investigational drug radium-223 chloride to patients diagnosed with castration-resistant prostate cancer (CRPC)/hormone-refractory prostate cancer (HRPC) with symptomatic bone metastases. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661361 Thu, 02 Feb 2012 11:00:00 +0100 5661361 http://www.medworm.com/index.php?rid=5661362&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FDel-Mar-Pharmaceuticals-Granted-US-Orphan-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da DelMar Pharma today announced that the United States FDA Office of Orphan Products Development has granted orphan drug designation for VAL-083 for the treatment of glioma, including glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661362 Thu, 02 Feb 2012 10:36:00 +0100 5661362 http://www.medworm.com/index.php?rid=5661363&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAstraZenecas-New-Restructuring-Initiatives-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da In conjunction with the publication of its full year 2011 results earlier recently, AstraZeneca announced new restructuring initiatives designed to improve productivity and strengthen the company's commercial, operations and research and development capabilities. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661363 Thu, 02 Feb 2012 10:25:00 +0100 5661363 http://www.medworm.com/index.php?rid=5661364&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNorwich-Expands-Capabilities-For-Phase-I-III-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, recently announced a significant expansion to its clinical research capabilities in order to meet growing market demand. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661364 Thu, 02 Feb 2012 10:12:00 +0100 5661364 http://www.medworm.com/index.php?rid=5651560&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FEXCELLA-GmbH-API-Plant-Achieves-SafeBridge-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da SAFEBRIDGE CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, has announced that Excella GmbH ("Excella") in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") at their chemical plant located in Feucht. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651560 Thu, 02 Feb 2012 09:57:00 +0100 5651560 http://www.medworm.com/index.php?rid=5661365&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FOctoPlus-Enters-Into-Drug-Development-And-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661365 Thu, 02 Feb 2012 09:11:00 +0100 5661365 http://www.medworm.com/index.php?rid=5661366&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNextPharma-Technologies-Hosts-Inauguration-0002%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce the official opening of its "state of the art" Cold Chain and Logistics (CLS) warehouse in Werne, Germany at an inauguration ceremony attended by local dignitaries and many of NextPharma's customers. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661366 Wed, 01 Feb 2012 09:33:00 +0100 5661366 http://www.medworm.com/index.php?rid=5651561&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Approves-KALYDECO-Ivacaftor-The-First-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Vertex Pharmaceuticals Incorporated announced recently that the U.S. Food and Drug Administration (FDA) has approved KALYDECOTM (ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF), a rare, genetic disease. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651561 Tue, 31 Jan 2012 18:33:00 +0100 5651561 http://www.medworm.com/index.php?rid=5651562&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNPS-Pharmaceuticals-Announces-FDA-Acceptance-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, recently announced the U.S. Food and Drug Administration (FDA) has accepted and filed for review the company's New Drug Application (NDA) for GATTEX (teduglutide) for the treatment of adults with short bowel syndrome or SBS. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651562 Tue, 31 Jan 2012 13:00:00 +0100 5651562 http://www.medworm.com/index.php?rid=5651564&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBionest-And-PMC-Address-Optimization-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bionest Partners, a premier strategy and management consulting firm for life science industries, and a recognized leader in personalized medicine strategy consulting, announces the publication of an article in a supplement to the Dec. 23, 2011 issue of Science. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651564 Tue, 31 Jan 2012 12:00:00 +0100 5651564 http://www.medworm.com/index.php?rid=5651563&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAlkermes-Initiates-Open-Label-Pilot-Study-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Alkermes plc recently announced the initiation of a pilot study of VIVITROL (naltrexone for extended-release injectable suspension) in prisoners with a pre-incarceration history of opioid dependence. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651563 Tue, 31 Jan 2012 12:00:00 +0100 5651563 http://www.medworm.com/index.php?rid=5661367&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FDSM-Announces-Marketing-And-Sales-Alliance-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Royal DSM N.V., recently announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5661367 Tue, 31 Jan 2012 10:26:00 +0100 5661367 http://www.medworm.com/index.php?rid=5651565&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FILC-Dovers-Sentinel-XT-PAPR-Receives-0002%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da ILC Dover, the manufacturer of Innovative Protective Equipment for the most demanding applications including spacesuits for NASA, announced recently that the National Institute for Occupational Safety and Health has approved its Sentinel XT as a Loose Fitting Powered Air Purifying Respirator (PAPR) (TC-21C-0901). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651565 Tue, 31 Jan 2012 08:25:00 +0100 5651565 http://www.medworm.com/index.php?rid=5651566&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFlexCessory-Stand-Aids-Single-Use-Fluid-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Meissner offers a stainless steel FlexCessory stand to secure and support FlexFill single-use fluid transfer assemblies during use. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651566 Tue, 31 Jan 2012 07:33:00 +0100 5651566 http://www.medworm.com/index.php?rid=5651567&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMarken-Announces-New-Corporate-Team-To-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Marken announced recently the introduction of 'CORTEC', an internal corporate function led by industry experts to support the development of industry best practices, packaging technology and innovation. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651567 Tue, 31 Jan 2012 06:30:00 +0100 5651567 http://www.medworm.com/index.php?rid=5651568&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FRoche-commences-tender-offer-for-Illumina-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Roche (SIX: RO, ROG; OTCQX: RHHBY), a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, announced today that it has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651568 Mon, 30 Jan 2012 19:14:09 +0100 5651568 http://www.medworm.com/index.php?rid=5651569&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FWatson-Announces-New-Jersey-Based-Global-RD-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651569 Mon, 30 Jan 2012 10:49:00 +0100 5651569 http://www.medworm.com/index.php?rid=5651570&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FIntroducing-A-New-Unique-Turnkey-Isolated-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The results of a unique collaboration between four market leading companies serving the powder processing industries will be unveiled on Booth #2443 at Interphex 2012 (1-3 May; New York, USA). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651570 Mon, 30 Jan 2012 09:04:00 +0100 5651570 http://www.medworm.com/index.php?rid=5651571&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Approves-Erivedge-vismodegib-Capsule-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Roche recently announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651571 Mon, 30 Jan 2012 08:31:00 +0100 5651571 http://www.medworm.com/index.php?rid=5651572&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FRoss-Moves-Into-New-Plant-In-India-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Charles Ross & Son Company, Vice President of Corporate Operations, Joe Martorana announces the relocation of Ross Process Equipment (RPE) into a new state-of-the-art plant in Pune, India tripling the size of its previous facility. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651572 Mon, 30 Jan 2012 08:25:00 +0100 5651572 http://www.medworm.com/index.php?rid=5651573&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPrivate-And-Public-Partners-Unite-To-Combat-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Recently, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651573 Mon, 30 Jan 2012 08:18:00 +0100 5651573 http://www.medworm.com/index.php?rid=5651574&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FUBM-Canon-Pharmaceutical-Group-Announces-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da UBM Canon, the global authority for the advanced manufacturing and medical device industries, announced today a reorganization between the Pharmaceutical Media Group and Data Products teams to provide an integrated, holistic media solution for clients and audience alike. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651574 Mon, 30 Jan 2012 07:57:00 +0100 5651574 http://www.medworm.com/index.php?rid=5651575&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Approves-BYDUREON-The-First-And-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved BYDUREON™ (exenatide extended-release for injectable suspension) - the first once-weekly treatment for type 2 diabetes. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651575 Fri, 27 Jan 2012 08:58:00 +0100 5651575 http://www.medworm.com/index.php?rid=5639968&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FQuadro-Engineering-And-Microfluidics-To-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Quadro Engineering and Microfluidics recently announced that they will be presenting a free webinar on vaccine development using high shear energy technologies. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5639968 Fri, 27 Jan 2012 04:20:00 +0100 5639968 http://www.medworm.com/index.php?rid=5651576&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBiochrom-WPA-Spectrophotometers-Now-Available-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da For the first time, WPA users have the opportunity to control their spectrophotometer from a Windows PC. Resolution software is available in four different suites that enable users to meet individual application requirements. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651576 Fri, 27 Jan 2012 04:00:00 +0100 5651576 http://www.medworm.com/index.php?rid=5651577&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FConferee-Networking-Sessions-For-Pittcon-2012-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The Pittcon Networking Committee is pleased to announce the topics for the Conferee Networking Sessions for Pittcon 2012 which will be held from March 11 through March 15, at the Orange County Convention Center, Orlando, Florida. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5651577 Thu, 26 Jan 2012 09:02:00 +0100 5651577 http://www.medworm.com/index.php?rid=5639969&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FProductivity-Gains-Using-Mastersizer-3000-Add-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Particle size analysis of raw materials is often a necessary but routine task where speed and efficiency are critical to decision-making and the smooth operation of a manufacturing process. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5639969 Thu, 26 Jan 2012 07:36:00 +0100 5639969 http://www.medworm.com/index.php?rid=5639970&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FGrace-Announces-Patent-Notice-Of-Allowance-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da W. R. Grace & Co. is pleased to announce that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application related to its REVELERIS flash chromatography system. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5639970 Wed, 25 Jan 2012 06:52:00 +0100 5639970 http://www.medworm.com/index.php?rid=5631194&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFlexStation-Accessories-Enhance-Mobility-For-0002%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da FlexStation™ rigid outer containers are now available with optional accessories for enhanced mobility. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631194 Wed, 25 Jan 2012 06:11:00 +0100 5631194 http://www.medworm.com/index.php?rid=5631195&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FTwo-New-Videos-Demonstrate-Self-Deploying-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da TepoFlex® polyethylene (PE) biocontainer demonstration videos for biomanufacturing applications. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631195 Wed, 25 Jan 2012 05:22:00 +0100 5631195 http://www.medworm.com/index.php?rid=5631196&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFlexFill-Single-Use-Biocontainers-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da FlexFill™ single-use biocontainers are best suited for applications requiring fast and dependable aseptic transfer of small liquid process volumes. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631196 Wed, 25 Jan 2012 04:57:00 +0100 5631196 http://www.medworm.com/index.php?rid=5631197&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBioFlex-Tubing-And-Assemblies-Offer-Maximum-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bioflex single-use tubing and filter/tubing assemblies offer maximum convenience and flexibility in single-use systems. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631197 Wed, 25 Jan 2012 04:29:00 +0100 5631197 http://www.medworm.com/index.php?rid=5631198&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FTepoFlex-Single-Use-Biocontainers-Provide-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da TepoFlex® biocontainers for single-use systems offers the highest combined gas and water vapor barrier properties in the biopharmaceutical industry. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631198 Wed, 25 Jan 2012 04:19:00 +0100 5631198 http://www.medworm.com/index.php?rid=5631199&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBioLineRx-Signs-Exclusive-License-Agreement-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da BioLineRx, a biopharmaceutical development company, announced recently it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C. BL-8020 has been developed for anti-viral therapy by Professor Philippe Halfon, Co-Founder and President of Genoscience. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631199 Tue, 24 Jan 2012 12:00:00 +0100 5631199 http://www.medworm.com/index.php?rid=5631200&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMembrana-Launches-Online-Membrane-Contactor-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Membrana-Charlotte, a Division of Celgard, LLC, recently announced the launch of the new online store, for membrane contactors. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631200 Tue, 24 Jan 2012 09:44:00 +0100 5631200 http://www.medworm.com/index.php?rid=5631201&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAptar-Pharma-Expands-Presence-In-India-With-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Aptar Pharma, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices, recently announces the opening of a new facility near Mumbai, India. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631201 Tue, 24 Jan 2012 08:58:00 +0100 5631201 http://www.medworm.com/index.php?rid=5631202&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBoehringer-Ingelheim-Prolongates-Drug-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Priaxon, utilizing its proprietory PriaXplore® platform for small molecule drug discovery, and Boehringer Ingelheim will prolongate their research and development collaboration on mdm2/p53 inhibitors for the treatment of cancer. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631202 Tue, 24 Jan 2012 05:59:00 +0100 5631202 http://www.medworm.com/index.php?rid=5631203&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPernix-Therapeutics-Announces-Agreement-To-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, recently announced it has entered into a license and supply agreement with a private company for a new FDA-approved prescription product to treat gastroenterology disease. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631203 Mon, 23 Jan 2012 13:30:00 +0100 5631203 http://www.medworm.com/index.php?rid=5631204&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAPP-Pharmaceuticals-Settles-With-The-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced recently that it has settled its litigation with The Medicines Company relating to APP's Abbreviated New Drug Application for a generic version of the anti-clotting drug Angiomax (bivalirudin for injection). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631204 Mon, 23 Jan 2012 12:30:00 +0100 5631204 http://www.medworm.com/index.php?rid=5631205&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSartorius-Stedim-Biotech-And-Refine-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Sartorius Stedim Biotech (SSB), a leading international pharma supplier, and Refine Technology (Refine), the developer and worldwide supplier to the biotech industry of the ATF. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631205 Mon, 23 Jan 2012 12:12:00 +0100 5631205 http://www.medworm.com/index.php?rid=5631206&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPerrigo-Confirms-Filing-For-Generic-Version-0002%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631206 Mon, 23 Jan 2012 09:29:00 +0100 5631206 http://www.medworm.com/index.php?rid=5631207&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FValue-Plastics-A-Nordson-Company-Improves-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Value Plastics, a Nordson Company, introduces a technologically advanced series of ports for the single-use bags used to transfer media and drug compounds in the biopharmaceutical industry. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631207 Mon, 23 Jan 2012 06:15:00 +0100 5631207 http://www.medworm.com/index.php?rid=5621710&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FWalker-Barrier-Systems-Announces-The-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Walker Barrier Systems is pleased to announce that they will assume the service and support for all Extract Technology's equipment throughout North and South America, effective January 1, 2012. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621710 Mon, 23 Jan 2012 05:55:00 +0100 5621710 http://www.medworm.com/index.php?rid=5621711&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FWaters-And-NIBRT-Complete-Work-On-Worlds-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Waters Corporation (WAT:NYSE) and Ireland's National Institute for Bioprocessing Research and Training (NIBRT) announced today the availability of the world's first database for glycan analysis by UltraPerformance Liquid Chromatography® (UPLC®). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621711 Sat, 21 Jan 2012 04:42:00 +0100 5621711 http://www.medworm.com/index.php?rid=5631208&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Updates-TYSABRI-Natalizumab-Label-To-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Recently Biogen Idec and Elan Corporation, plc announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis (MS). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631208 Fri, 20 Jan 2012 21:40:00 +0100 5631208 http://www.medworm.com/index.php?rid=5631209&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FGenzyme-And-Veracyte-Announce-Global-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Genzyme, a Sanofi company and one of the world's leading biotechnology companies, and Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, recently announced a global co-promotion partnership to provide a comprehensive solution for thyroid patients. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631209 Fri, 20 Jan 2012 13:15:00 +0100 5631209 http://www.medworm.com/index.php?rid=5621712&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FLa-Jolla-Pharmaceutical-Company-Acquires-GCS-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da La Jolla Pharmaceutical Company (the "Company" and "La Jolla") recently announced that it has acquired global development and commercialization rights to GCS-100, a novel therapeutic, from privately held Solana Therapeutics, Inc. ("Solana"). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621712 Fri, 20 Jan 2012 13:00:00 +0100 5621712 http://www.medworm.com/index.php?rid=5631210&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FInsmed-Incorporated-Provides-Corporate-Update-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on ARIKACE® (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacteria (NTM) lung disease. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5631210 Fri, 20 Jan 2012 07:03:00 +0100 5631210 http://www.medworm.com/index.php?rid=5621713&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPolyTherics-Acquires-Warwick-Effect-Polymers-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da PolyTherics Limited ("PolyTherics"), a provider of solutions to biopharmaceutical companies for the improvement of protein and peptide based drugs, is pleased to announce the acquisition of Warwick Effect Polymers ("WEP"), a provider of specialty biopolymers for the modification of biological products. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621713 Fri, 20 Jan 2012 05:59:00 +0100 5621713 http://www.medworm.com/index.php?rid=5612256&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FIntroducing-The-ChargePoint-BIO-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da ChargePoint Technology® are pleased to announce the official launch of the ChargePoint® BIO aseptic transfer valve, setting new standards for the safe and clean transfer of sensitive product from process to process. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612256 Fri, 20 Jan 2012 05:38:00 +0100 5612256 http://www.medworm.com/index.php?rid=5612257&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FChargePoint-Technology-Launches-New-Improved-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The contained transfer of API's from process to process now easier than ever with the new ChargeBag®. Key specification changes for enhanced product flow, extended shelf life and global compliance ensures the new product offers improved performance and quality. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612257 Fri, 20 Jan 2012 05:26:00 +0100 5612257 http://www.medworm.com/index.php?rid=5621714&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAvila-Announces-FDA-Allowance-Of-Partner-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved the first milestone in its Epidermal Growth Factor Receptor (EGFR) Mutant-Selective Inhibitor (EMSI) alliance with Clovis Oncology triggering a $4M milestone payment to Avila. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621714 Thu, 19 Jan 2012 22:45:00 +0100 5621714 http://www.medworm.com/index.php?rid=5612258&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPatheon-Adds-Soft-Gel-Capsule-Capabilities-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612258 Thu, 19 Jan 2012 10:05:00 +0100 5612258 http://www.medworm.com/index.php?rid=5621715&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMylan-Launches-Innovative-Version-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL, 1000 mg/100 mL and 1500 mg/100 mL, for intravenous use. Mylan's launch of this new product, which has been approved by the U.S. Food and Drug Administration (FDA), marks the first time that multiple strengths (500 mg, 1000 mg and 1500 mg) of premixed Levetiracetam will be supplied in ready-to-administer bags of Sodium Chloride Injection (100 mL). This product is an antiepileptic drug indicated for certain types of seizures. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621715 Thu, 19 Jan 2012 06:35:00 +0100 5621715 http://www.medworm.com/index.php?rid=5612259&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSouthwest-Airlines-Reports-Fourth-Quarter-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Southwest Airlines Co.(the "Company") recently reported its fourth quarter and full year 2011 results. Fourth quarter 2011 net income was $152M, or $.20 per diluted share, which included $86M (net) of favorable special items. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612259 Thu, 19 Jan 2012 05:31:00 +0100 5612259 http://www.medworm.com/index.php?rid=5621716&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FUS-Food-And-Drug-Administration-Approves-0002%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Gilead Sciences, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved Viread (tenofovir disoproxil fumarate) in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5621716 Thu, 19 Jan 2012 00:15:00 +0100 5621716 http://www.medworm.com/index.php?rid=5612260&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAPR-Applied-Pharma-Research-sa-Labtec-GmbH-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm Ondansetron Oral Dispersible Film ("ODF"), in Europe and selected non-European countries. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612260 Wed, 18 Jan 2012 13:00:00 +0100 5612260 http://www.medworm.com/index.php?rid=5612261&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSartorius-Stedim-Biotech-And-G-Con-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Sartorius Stedim Biotech (SSB) and G-Con have agreed to a global collaboration to offer highly advanced and flexible production platforms for the biopharmaceutical manufacturing industry. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612261 Wed, 18 Jan 2012 09:14:00 +0100 5612261 http://www.medworm.com/index.php?rid=5612262&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMicroActive-Micromeritics-New-Innovative-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Micromeritics' new innovative MicroActive data analysis software allows users to interactively evaluate isotherm data from Micromeritics' ASAP, TriStar, and Gemini gas adsorption instruments. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612262 Wed, 18 Jan 2012 08:34:00 +0100 5612262 http://www.medworm.com/index.php?rid=5612263&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMalvern-Rheology-Expert-Contributes-Chapter-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Dr Samiul Amin, Strategic Technology Group Manager at Malvern Instruments has collaborated with Dr Krassimir P. Velikov from Unilever R&D Vlaardingen to provide a chapter examining the 'Rheology of Complex Fluids Containing Nutraceuticals', in a recently published book for industry professionals. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612263 Wed, 18 Jan 2012 07:06:00 +0100 5612263 http://www.medworm.com/index.php?rid=5612264&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FGenzyme-Announces-European-Approval-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Genzyme, a Sanofi company, announced recently that the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme (agalsidase beta). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612264 Wed, 18 Jan 2012 06:00:00 +0100 5612264 http://www.medworm.com/index.php?rid=5600139&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFilamatic-To-Exhibit-And-Demonstrate-Machine-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Baltimore, MD-Filamatic will be exhibiting at this year's Interphex show held at the Jacob Javits Convention Center, New York, NY on May 1st-3rd. Filamatic's booth 2828 will feature an interactive experience for the pharmaceutical industry. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600139 Wed, 18 Jan 2012 06:00:00 +0100 5600139 http://www.medworm.com/index.php?rid=5600140&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMarken-Expands-Clinical-Trial-Distribution-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Marken is pleased to announce that Dr. Andrea Zobel has joined Marken in the new role of Senior Director, CTD Operations. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600140 Wed, 18 Jan 2012 05:04:00 +0100 5600140 http://www.medworm.com/index.php?rid=5612265&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAgilent-Technologies-Lists-LC-And-Mass-Spec-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Agilent Technologies Inc. recently announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612265 Tue, 17 Jan 2012 16:00:00 +0100 5612265 http://www.medworm.com/index.php?rid=5600141&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FValeant-Pharmaceuticals-Increases-Proposed-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has increased from $6.50 to $7.50 per share in cash the proposed price of its previously announced offer to acquire ISTA Pharmaceuticals Inc. (Nasdaq: ISTA). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600141 Tue, 17 Jan 2012 15:42:34 +0100 5600141 http://www.medworm.com/index.php?rid=5600142&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Accepts-Lorcaserin-New-Drug-Application-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has accepted for filing and review Arena's resubmission of the New Drug Application (NDA) for lorcaserin. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600142 Tue, 17 Jan 2012 15:08:58 +0100 5600142 http://www.medworm.com/index.php?rid=5600143&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNanohale-AG-Acquires-RD-And-Service-Units-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Scil Technology GmbH and Nanohale AG today announced that Nanohale has acquired the entire R&D, contract development and manufacturing organization of Scil Technology GmbH in an asset deal, effective December 31, 2011. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600143 Tue, 17 Jan 2012 14:19:18 +0100 5600143 http://www.medworm.com/index.php?rid=5612266&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAlnylam-Files-Patent-Infringement-Suit-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced recently that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of the District of Massachusetts. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612266 Tue, 17 Jan 2012 14:08:00 +0100 5612266 http://www.medworm.com/index.php?rid=5612267&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSmiths-Detection-Launches-Next-Generation-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Smiths Detection has unveiled a next-generation chemical threat detector that combines high speed, high-resolution gas chromatography (GC) and a miniaturized toroidal ion trap mass spectrometer (MS) in a portable device. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612267 Tue, 17 Jan 2012 14:00:00 +0100 5612267 http://www.medworm.com/index.php?rid=5600144&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMedivation-and-Pfizer-Announce-Results-from-P-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Medivation, Inc.(NASDAQ: MDVN) and Pfizer Inc. (NYSE: PFE) today announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer's disease. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600144 Tue, 17 Jan 2012 12:00:00 +0100 5600144 http://www.medworm.com/index.php?rid=5600145&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FJPT-Peptide-Technologies-IUCT-and-LEITAT-Anno-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy based on the biofocused targeting of nucleoside analogs linked to small cyclic peptidomimetics. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600145 Tue, 17 Jan 2012 11:24:00 +0100 5600145 http://www.medworm.com/index.php?rid=5612268&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMGB-Biopharma-And-Almac-Collaborate-On-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5612268 Tue, 17 Jan 2012 10:13:00 +0100 5612268 http://www.medworm.com/index.php?rid=5600146&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FScil-Proteins-to-Manufacture-Reteplase-for-Ac-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600146 Tue, 17 Jan 2012 09:00:00 +0100 5600146 http://www.medworm.com/index.php?rid=5600147&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FGenevac-Announces-Sports-Drug-Testing-Lab-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Genevac has announced an applications report that details how its miVac Duo sample concentrator has been used by a leading testing laboratory to develop a new sample preparation method to help curb sports doping. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600147 Tue, 17 Jan 2012 05:35:00 +0100 5600147 http://www.medworm.com/index.php?rid=5600148&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNew-And-Improved-Packaging-From-International-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da International Products Corporation (IPC) is pleased to announce the transition to new packaging is now complete. The company introduced new, updated packaging in 2011. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600148 Tue, 17 Jan 2012 05:17:00 +0100 5600148 http://www.medworm.com/index.php?rid=5600149&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSynta-Announces-Publication-Of-Results-Showin-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Synta Pharmaceuticals (NASDAQ: SNTA) - Ganetespib, a non-ansamycin inhibitor of Hsp90, enhances the activity of the microtubule targeting docetaxel, paclitaxel, and vincristine in multiple non-small cell lung cancer (NSCLC) xenograft models according to an article published in the journal Investigational New Drugs. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600149 Mon, 16 Jan 2012 16:16:00 +0100 5600149 http://www.medworm.com/index.php?rid=5600150&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAstex-Announces-Early-Transfer-of-Epigenetics-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) today announced that the multi-year collaboration to discover cancer therapeutics based on epigenetic targets entered into by SuperGen, Inc. and GlaxoSmithKline (GSK) in November 2009 is terminating and existing research work and assets generated under the CLIMBT epigenetic collaboration will be transferred to GSK. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600150 Mon, 16 Jan 2012 11:00:00 +0100 5600150 http://www.medworm.com/index.php?rid=5600151&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FCharles-Ross-Son-Announces-Free-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Process engineers and R&D scientists have a new technical resource for their mixing and blending related questions at the Charles Ross & Son Company. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600151 Mon, 16 Jan 2012 06:02:00 +0100 5600151 http://www.medworm.com/index.php?rid=5586158&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FKedem-Pharmaceuticals-Initiates-Development-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty pharmaceutical company with focus on sublingual drug delivery system is pleased to announce that has initiated the development of Gleevec®. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586158 Thu, 12 Jan 2012 07:04:00 +0100 5586158 http://www.medworm.com/index.php?rid=5586159&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FWALDNER-DOSOMAT-POUCH-Filling-And-Sealing-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The recent issue of the Waldner Brief Magazine featured an informative article regarding standup pouches and flexible packaging. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586159 Thu, 12 Jan 2012 04:14:00 +0100 5586159 http://www.medworm.com/index.php?rid=5586160&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2Fmicrobiology-laboratory-iso-accreditation-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Covance Microbiology Laboratory receives ISO accreditation recognized for meeting highest international regularoty, safety standards. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586160 Wed, 11 Jan 2012 16:38:00 +0100 5586160 http://www.medworm.com/index.php?rid=5600152&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMicrotest-Laboratories-Will-Manufacture-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Microtest Laboratories has announced that the company will manufacture and provide supporting pharmaceutical testing services for ImmusanT, Inc.'s Nexvax2 immunotherapeutic vaccine for its expected upcoming clinical trial. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5600152 Wed, 11 Jan 2012 14:15:00 +0100 5600152 http://www.medworm.com/index.php?rid=5586161&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNovartis-Takes-120M-Hit-With-Plant-Closure-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Last month, Novartis halted operations at its Lincoln, NE, plant, where it manufactured and shipped over-the-counter drugs, following consumer complaints of broken gelcaps and chipped tablets. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586161 Wed, 11 Jan 2012 12:37:11 +0100 5586161 http://www.medworm.com/index.php?rid=5586162&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPharmaceutical-Institute-Integrates-Preceptiv-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Pharmaceutical Institute, a subsidiary of Campbell Alliance, the Consulting business segment of inVentiv Health, Inc., today announced the completion of its integration of Preceptiv Learning Solutions into its operations. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586162 Wed, 11 Jan 2012 08:25:00 +0100 5586162 http://www.medworm.com/index.php?rid=5586163&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FInnovative-Energy-Efficient-Milling-Solutions-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da International Innovative Technologies (IIT, Gateshead, UK) is working in partnership with Malvern Instruments to incorporate new in-line particle size distribution analysis systems in its specialist low energy milling equipment. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586163 Wed, 11 Jan 2012 06:54:00 +0100 5586163 http://www.medworm.com/index.php?rid=5586164&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FINTERPHEX-Announces-2012-Advisory-Board-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The organizers of INTERPHEX have announced the selection of the event's 2012 Advisory Board, the volunteer panel of industry experts whose insights play a strong role in determining the event's conference programs and direction. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586164 Wed, 11 Jan 2012 06:19:00 +0100 5586164 http://www.medworm.com/index.php?rid=5586165&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFleming-Pharmaceuticals-Sells-Ocean-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Fleming Pharmaceuticals announced today that, effective December 22, 2011, it has sold its rights to its branded Ocean®, Nephrocaps®, Magonate® and ProBarimin QT® products to Valeant International (Barbados) SRL ("Valeant"). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586165 Wed, 11 Jan 2012 05:21:00 +0100 5586165 http://www.medworm.com/index.php?rid=5586166&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FCryoPort-Frozen-Shipping-Solution-On-CBS-60-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da CryoPort, Inc. was mentioned in a 60 MINUTES story Sunday night as the "highest medical standard" for safely and securely transporting cryogenically frozen materials. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586166 Tue, 10 Jan 2012 16:58:00 +0100 5586166 http://www.medworm.com/index.php?rid=5586167&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FQuality-Management-Systems-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The adoption of a QMS needs to be a strategic decision of an organisation, and is influenced by varying needs, objectives, the products/services provided, the processes employed and the size and structure of the organisation. A QMS must ensure that the products/services conform to customer needs and expectations, and the objectives of the organisation. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586167 Tue, 10 Jan 2012 13:17:00 +0100 5586167 http://www.medworm.com/index.php?rid=5586168&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FDFH-Pharma-To-Collaborate-With-National-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da DFH Pharma, Inc., (DFH) a privately held specialty pharmaceutical company focused exclusively in the HIV-1 therapeutic space, announced today a collaborative agreement between DFH and the National Cancer Institute (NCI) to further the development of the next generation of HIV maturation inhibitor drugs. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586168 Tue, 10 Jan 2012 08:51:00 +0100 5586168 http://www.medworm.com/index.php?rid=5586169&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FShangPharma-Announces-Opening-Of-New-Facility-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has opened a new facility to meet the growing capacity needs of one of its largest customers, Eli Lilly and Company ("Lilly"). ShangPharma also announced that it has signed a multi-year extension of its contract with Lilly. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586169 Tue, 10 Jan 2012 07:16:00 +0100 5586169 http://www.medworm.com/index.php?rid=5586170&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FUCSF-Sanofi-Collaborate-To-Find-New-Diabetes-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company Sanofi (EURONEXT: SAN and NYSE: SNY) to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586170 Tue, 10 Jan 2012 06:55:00 +0100 5586170 http://www.medworm.com/index.php?rid=5586171&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSP-Scientific-Announces-Freeze-Drying-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Presented by Dr Kevin Ward from Biopharma Technology Ltd. - the 24th January 2012 webinar examines a study which discusses and shows how red blood cells can be successfully freeze dried and rehydrated with minimal degradation. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586171 Tue, 10 Jan 2012 05:29:00 +0100 5586171 http://www.medworm.com/index.php?rid=5586172&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FXenon-To-Collaborate-With-Genentech-On-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Xenon today announced a strategic alliance with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to discover and develop compounds and companion diagnostics for the potential treatment of pain. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586172 Tue, 10 Jan 2012 04:39:00 +0100 5586172 http://www.medworm.com/index.php?rid=5586173&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FIn-The-Brain-ORMOSIL-Nanoparticles-Hold-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da In the images of fruit flies, clusters of neurons are all lit up, forming a brightly glowing network of highways within the brain. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586173 Tue, 10 Jan 2012 04:29:00 +0100 5586173 http://www.medworm.com/index.php?rid=5586174&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FHospira-Announces-Start-Of-US-Phase-III-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced enrollment of the first patient in a Phase III U.S. clinical program for its biosimilar erythropoietin (EPO). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586174 Tue, 10 Jan 2012 04:26:00 +0100 5586174 http://www.medworm.com/index.php?rid=5586175&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBayer-HealthCare-To-Share-Lab-Space-With-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da One year after the opening of its U.S. Innovation Center, Bayer HealthCare is expanding its U.S. research model. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586175 Mon, 09 Jan 2012 05:41:00 +0100 5586175 http://www.medworm.com/index.php?rid=5586176&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBristol-Myers-Squibb-To-Acquire-Inhibitex-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bristol-Myers Squibb Company (NYSE:BMY) and Inhibitex, Inc. (Nasdaq:INHX) announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5586176 Sun, 08 Jan 2012 02:13:00 +0100 5586176 http://www.medworm.com/index.php?rid=5562940&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-Update-Drug-Shortage-Ranbaxy-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da On December 15, The FDA issued an interim final rule to help prevent prescription drug shortages. The agency now requires pharmaceutical manufacturers to report all production interruptions of drugs that are life supporting or life sustaining, or that prevent a debilitating condition. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562940 Thu, 05 Jan 2012 16:30:00 +0100 5562940 http://www.medworm.com/index.php?rid=5562941&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FTargacept-Announces-Decision-By-AstraZeneca-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, recently announced that AstraZeneca has informed the company that it plans to progress the development of Targacept's product candidate AZD1446 as a treatment for Alzheimer's disease. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562941 Thu, 05 Jan 2012 13:55:00 +0100 5562941 http://www.medworm.com/index.php?rid=5573534&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFORMA-Therapeutics-Announces-Collaboration-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da FORMA Therapeutics announced recently that the Company has entered into a research and development collaboration with Boehringer Ingelheim to discover and develop novel drug candidates for the treatment of cancer. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5573534 Thu, 05 Jan 2012 13:30:00 +0100 5573534 http://www.medworm.com/index.php?rid=5562942&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FUnited-Cargo-Accepts-OnAsset-SENTRY-400-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da OnAsset Intelligence, a leading provider of machine-to-machine (M2M) wireless asset tracking solutions, recently announced that United Cargo, the world's largest belly carrier, is now accepting the OnAsset SENTRY 400 FlightSafe device for transport on its entire mainline jet fleet of more than 700 aircraft, linking more than 370 worldwide destinations. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562942 Thu, 05 Jan 2012 05:02:00 +0100 5562942 http://www.medworm.com/index.php?rid=5562943&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBiogen-Idec-And-Isis-Pharmaceuticals-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Biogen Idec and Isis Pharmaceuticals, Inc. recently announced that they have entered into an exclusive, worldwide option and collaboration agreement under which the companies will develop and commercialize Isis' antisense investigational drug, ISIS-SMNRx, for the treatment of spinal muscular atrophy (SMA). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562943 Wed, 04 Jan 2012 13:30:00 +0100 5562943 http://www.medworm.com/index.php?rid=5562944&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FDr-Jeremy-Levin-A-Former-Senior-Executive-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Phillip Frost, MD, Chairman of the Board of Directors of Teva Pharmaceutical Industries Ltd., announced recently that Shlomo Yanai, President and CEO of Teva, plans to retire from the company effective May 2012, and that as part of a succession plan, the Board of Directors has named Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb, to succeed him at that time. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562944 Wed, 04 Jan 2012 07:06:00 +0100 5562944 http://www.medworm.com/index.php?rid=5562945&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FHalo-Therapeutics-HT-100-Receives-FDAs-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, today announced that the United States Food and Drug Administration (FDA) granted orphan drug designation for HT-100 for treatment of Duchenne muscular dystrophy (DMD). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562945 Wed, 04 Jan 2012 06:43:00 +0100 5562945 http://www.medworm.com/index.php?rid=5562946&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FKedem-Pharmaceuticals-Engages-A-FDA-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to announce that it has signed a contract with a GMP pharmaceutical FDA compliant formulation development company, Corealis Pharma, Inc. for the production of the phase I clinical supplies of KDM-1102, the Company's second lead therapeutic drug. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562946 Wed, 04 Jan 2012 06:03:00 +0100 5562946 http://www.medworm.com/index.php?rid=5562947&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPew-Applauds-FDA-Measure-To-Preserve-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The Pew Campaign on Human Health and Industrial Farming today praised the U.S. Food and Drug Administration (FDA) for limiting the use of cephalosporins in food animal production. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562947 Wed, 04 Jan 2012 05:48:00 +0100 5562947 http://www.medworm.com/index.php?rid=5562948&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMerz-Pharmaceuticals-Receives-J-Code-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 "INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT" for Xeomin® (incobotulinumtoxinA), effective beginning January 1, 2012. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562948 Wed, 04 Jan 2012 05:35:00 +0100 5562948 http://www.medworm.com/index.php?rid=5562949&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FElevation-Pharmaceuticals-Completes-30M-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Elevation Pharmaceuticals, Inc. announced today the closing of a $30 million Series B financing, led by new investor Novo Ventures, to fund development of Elevation's new aerosol therapy for patients living with chronic obstructive pulmonary disease (COPD). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562949 Wed, 04 Jan 2012 05:15:00 +0100 5562949 http://www.medworm.com/index.php?rid=5562950&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FCharles-Ross-Announces-Mixing-And-Melting-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Charles Ross & Son Company, maker of Ross mixers, dispersers and blenders, also caters to custom fabrication projects including storage tanks, pressure vessels and reactors. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562950 Wed, 04 Jan 2012 04:59:00 +0100 5562950 http://www.medworm.com/index.php?rid=5562951&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBioMarin-Announces-IND-For-BMN-111-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the Investigational New Drug (IND) application for BMN-111, an analog of C-type Natriuretic Peptide (CNP), for achondroplasia is active. The company expects to initiate the Phase 1 trial in the first quarter of 2012. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562951 Tue, 03 Jan 2012 08:59:00 +0100 5562951 http://www.medworm.com/index.php?rid=5562952&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBionovo-Announces-5M-Financing-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562952 Tue, 03 Jan 2012 08:37:00 +0100 5562952 http://www.medworm.com/index.php?rid=5562953&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FRegeneron-Announces-Settlement-Of-Patent-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company has entered into a non-exclusive license and partial settlement agreement (Agreement) with Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) relating to U.S. ophthalmic sales of EYLEAT (aflibercept) Injection. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562953 Tue, 03 Jan 2012 08:23:00 +0100 5562953 http://www.medworm.com/index.php?rid=5562954&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FFDA-To-Review-Potential-New-Use-Of-XGEVA-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562954 Thu, 29 Dec 2011 07:53:00 +0100 5562954 http://www.medworm.com/index.php?rid=5546276&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2Famri-actions-to-streamline-operations-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da AMRI Announces Additional Actions to Streamline Operations Actions Will Reduce Operating Costs, Improve Liquidity, and Enhance Client Service (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5546276 Tue, 27 Dec 2011 18:39:00 +0100 5546276 http://www.medworm.com/index.php?rid=5554000&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPerrigo-Announces-FDA-Final-Approval-For-0003%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets (5 mg). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5554000 Tue, 27 Dec 2011 07:58:00 +0100 5554000 http://www.medworm.com/index.php?rid=5554001&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMylan-Launches-First-Generic-Version-Of-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5554001 Tue, 27 Dec 2011 07:35:00 +0100 5554001 http://www.medworm.com/index.php?rid=5546277&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSitrof-Technologies-Introduces-Argus-Capture-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Sitrof Technologies, a leading provider of unstructured content management solutions for the life sciences industry, announced a new product recently, Sitrof Argus Capture powered by EMC InputAccel. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5546277 Tue, 27 Dec 2011 06:25:00 +0100 5546277 http://www.medworm.com/index.php?rid=5562955&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FUS-FDA-Accepts-New-Drug-Application-For-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Gilead Sciences, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5562955 Fri, 23 Dec 2011 22:15:00 +0100 5562955 http://www.medworm.com/index.php?rid=5539856&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSynageva-BioPharma-Completes-Enrollment-In-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Synageva BioPharma Corp., ("Synageva") a clinical stage biopharmaceutical company developing therapeutic products for rare disorders announced that it has completed enrollment in the first clinical trial of enzyme replacement for Lysosomal Acid Lipase (LAL) Deficiency. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5539856 Thu, 22 Dec 2011 13:00:00 +0100 5539856 http://www.medworm.com/index.php?rid=5546278&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMarken-Appoints-New-Head-Of-Global-Quality-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Marken announced recently that Steve Roese is named Vice President of Marken's Global Quality Assurance organization, which will support Marken's continued investment in their expanding network of pharmaceutical service depots around the world. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5546278 Thu, 22 Dec 2011 08:01:00 +0100 5546278 http://www.medworm.com/index.php?rid=5539857&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FEriez-Achieves-Record-Month-For-Shipments-In-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Tim Shuttleworth, Eriez President and CEO, announces that Eriez achieved a new record in November for the highest monthly shipment volume in the company's history. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5539857 Thu, 22 Dec 2011 06:46:00 +0100 5539857 http://www.medworm.com/index.php?rid=5554002&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FRanbaxy-Announces-Consent-Decree-With-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Ranbaxy Laboratories Ltd. ("Ranbaxy") recently announced that it has signed a consent decree with the U.S. Food and Drug Administration ("FDA"). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5554002 Thu, 22 Dec 2011 04:37:00 +0100 5554002 http://www.medworm.com/index.php?rid=5539858&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FAgilent-Technologies-Completes-Acquisition-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Agilent Technologies Inc. recently announced it has completed the acquisition of the BioSystem Development business. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5539858 Wed, 21 Dec 2011 16:00:00 +0100 5539858 http://www.medworm.com/index.php?rid=5539859&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FCall-For-USP-Monoclonal-Antibodies-Round-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da U.S. Pharmacopeia (USP) invites stakeholders, especially monoclonal antibody innovators and manufacturers, to participate in evaluating and setting standards for a newly developed USP general chapter Quality Attributes of Therapeutic Monoclonal Antibodies. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5539859 Wed, 21 Dec 2011 05:05:00 +0100 5539859 http://www.medworm.com/index.php?rid=5527934&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FMarken-Argentina-Pharmaceutical-Service-Depot-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Marken continues their expansion of services in Latin America, by augmenting their GMP Compliant depot network with the newly purpose-built Buenos Aires facility. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527934 Tue, 20 Dec 2011 15:25:08 +0100 5527934 http://www.medworm.com/index.php?rid=5527935&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FBASi-Reports-Fiscal-2011-Net-Income-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Bioanalytical Systems, Inc. (BASi) recently announced financial results for the fourth quarter and fiscal year ended September 30, 2011. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527935 Tue, 20 Dec 2011 06:59:00 +0100 5527935 http://www.medworm.com/index.php?rid=5527936&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FImproved-Powder-Injection-In-Batch-Mixing-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The Ross Solids/Liquid Injection Manifold (SLIM) is a high shear mixer system designed to accelerate the dispersion of hard-to-wet-out solids while eliminating floating powders in batch tanks and reducing dusting in the mixing area. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527936 Tue, 20 Dec 2011 04:26:00 +0100 5527936 http://www.medworm.com/index.php?rid=5527937&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FValeant-Pharmaceuticals-Completes-Acquisition-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that effective December 16, 2011, the company completed its previously announced acquisition of Dermik, a dermatology unit of Sanofi (EURONEXT: SAN and NYSE: SNY). (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527937 Tue, 20 Dec 2011 04:17:00 +0100 5527937 http://www.medworm.com/index.php?rid=5527938&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FCovidien-Plans-2B-Drug-Business-Spin-Off-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Healthcare products company Covidien announced Thursday that it is splitting up its pharmaceutical and medical device businesses. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527938 Mon, 19 Dec 2011 19:22:12 +0100 5527938 http://www.medworm.com/index.php?rid=5527939&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FNew-UCF-Nanotechnology-May-Speed-Up-Drug-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Testing the effectiveness of new pharmaceuticals may get faster thanks to a new technique incorporating quantum dots developed at the University of Central Florida. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527939 Mon, 19 Dec 2011 08:01:00 +0100 5527939 http://www.medworm.com/index.php?rid=5527940&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FPall-Corp-Signs-Agreement-To-Acquire-Life-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Pall Corporation, a global leader in filtration, separation and purification, recently announced it has entered into a definitive merger agreement to acquire ForteBio®, Inc., a leading provider of advanced analytical systems that accelerate the discovery and development of biotech drugs. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5527940 Mon, 19 Dec 2011 07:00:00 +0100 5527940 http://www.medworm.com/index.php?rid=5516875&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2Fminiature-nmr-spectrometer-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da The miniature NMR spectrometer technology is heralded as affordable and easy to use for research, process, and academia. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5516875 Fri, 16 Dec 2011 18:24:00 +0100 5516875 http://www.medworm.com/index.php?rid=5516876&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FTakeda-And-Affymax-Provide-Update-On-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Takeda Pharmaceutical Company Limited and Affymax, Inc. recently announced that Takeda has decided not to commercialize peginesatide in Japan. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5516876 Thu, 15 Dec 2011 21:00:00 +0100 5516876 http://www.medworm.com/index.php?rid=5507583&cid=s_37087_34_f&fid=37087&url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FVertex-Announces-CEO-Succession-Plan-For-2012-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da Vertex Pharmaceuticals Incorporated recently announced that its Board of Directors has appointed Jeffrey Leiden, M.D., Ph.D., to the position of President and Chief Executive Officer (CEO), effective February 1, 2012. (Source: Pharmaceutical Online News) Pharmaceutical Online News news http://www.medworm.com/rss/comments.php?id=5507583 Thu, 15 Dec 2011 12:45:00 +0100 5507583